Bill Maughan
Stock Analyst at Clear Street
(0.38)
# 4,137
Out of 5,122 analysts
20
Total ratings
40%
Success rate
-34.69%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Bill Maughan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRBU Caribou Biosciences | Initiates: Buy | $13 | $1.62 | +702.47% | 1 | Feb 2, 2026 | |
| CLLS Cellectis | Initiates: Buy | $9 | $3.54 | +154.24% | 1 | Dec 23, 2025 | |
| WVE Wave Life Sciences | Maintains: Buy | $22 → $47 | $13.33 | +252.59% | 2 | Dec 9, 2025 | |
| ANNX Annexon | Initiates: Buy | $17 | $6.04 | +181.46% | 1 | Dec 2, 2025 | |
| KRRO Korro Bio | Initiates: Buy | $93 | $12.26 | +658.56% | 1 | Oct 31, 2025 | |
| DNTH Dianthus Therapeutics | Initiates: Buy | $100 | $48.13 | +107.77% | 1 | Sep 17, 2025 | |
| KRYS Krystal Biotech | Initiates: Buy | $190 | $269.13 | -29.40% | 1 | Jul 1, 2025 | |
| CRSP CRISPR Therapeutics AG | Downgrades: Hold | $45 | $50.17 | -10.30% | 1 | Jun 27, 2025 | |
| NKTX Nkarta | Maintains: Buy | $16 → $15 | $2.05 | +631.71% | 2 | May 10, 2024 | |
| FATE Fate Therapeutics | Maintains: Buy | $11 → $9 | $1.15 | +682.61% | 1 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $63 → $67 | $31.56 | +112.29% | 3 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $91 → $106 | $42.77 | +147.84% | 3 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $24 | $1.78 | +1,252.11% | 1 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $5.72 | +948.95% | 1 | Feb 21, 2024 |
Caribou Biosciences
Feb 2, 2026
Initiates: Buy
Price Target: $13
Current: $1.62
Upside: +702.47%
Cellectis
Dec 23, 2025
Initiates: Buy
Price Target: $9
Current: $3.54
Upside: +154.24%
Wave Life Sciences
Dec 9, 2025
Maintains: Buy
Price Target: $22 → $47
Current: $13.33
Upside: +252.59%
Annexon
Dec 2, 2025
Initiates: Buy
Price Target: $17
Current: $6.04
Upside: +181.46%
Korro Bio
Oct 31, 2025
Initiates: Buy
Price Target: $93
Current: $12.26
Upside: +658.56%
Dianthus Therapeutics
Sep 17, 2025
Initiates: Buy
Price Target: $100
Current: $48.13
Upside: +107.77%
Krystal Biotech
Jul 1, 2025
Initiates: Buy
Price Target: $190
Current: $269.13
Upside: -29.40%
CRISPR Therapeutics AG
Jun 27, 2025
Downgrades: Hold
Price Target: $45
Current: $50.17
Upside: -10.30%
Nkarta
May 10, 2024
Maintains: Buy
Price Target: $16 → $15
Current: $2.05
Upside: +631.71%
Fate Therapeutics
May 10, 2024
Maintains: Buy
Price Target: $11 → $9
Current: $1.15
Upside: +682.61%
May 9, 2024
Maintains: Hold
Price Target: $63 → $67
Current: $31.56
Upside: +112.29%
May 3, 2024
Maintains: Hold
Price Target: $91 → $106
Current: $42.77
Upside: +147.84%
Mar 15, 2024
Maintains: Buy
Price Target: $22 → $24
Current: $1.78
Upside: +1,252.11%
Feb 21, 2024
Reiterates: Buy
Price Target: $60
Current: $5.72
Upside: +948.95%